Yahoo Italia Ricerca nel Web

Risultati di ricerca

1. www.jnj.comJohnson & Johnson: Changing health for humanity

   www.jnj.com

   • Cache

   2 giorni fa · Innovating in Health&Care. We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.

2. Immagini

   • 
   • 
   • 
   • 
   • 

   Mostra tutto

3. www.jnj.com › our-companyOur Company - Johnson & Johnson

   www.jnj.com › our-company

   • Cache

   13 ore fa · At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today we are committed to using our reach and size for good. We strive to improve access and affordability ...

4. www.jnj.com › media-center › press-releasesJohnson & Johnson Press Releases

   www.jnj.com › media-center › press-releases

   • Cache

   5 giorni fa · Johnson & Johnson advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA. PALOMA-3 presentation of subcutaneous amivantamab and lazertinib selected to showcase cutting-edge approaches in lung cancer during prestigious “Best of ASCO” program New data showcase first- and -best ...

5. www.bloomberg.com › news › articlesJ&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal

   www.bloomberg.com › news › articles

   • Cache

   5 giorni fa · May 28, 2024 at 5:46 AM PDT. Listen. 1:27. Johnson & Johnson agreed to pay $1.25 billion for the rights to an experimental eczema treatment, the latest big pharma deal for a new type of drug that ...

6. finanza.repubblica.it › News › 2024/05/28J&J acquista diritti di farmaco per disturbi della pelle per 1,25...

   finanza.repubblica.it › News › 2024/05/28

   • Cache

   5 giorni fa · J&J acquista diritti di farmaco per disturbi della pelle per 1,25 miliardi di dollari. (Teleborsa) - Johnson & Johnson, colosso statunitense della farmaceutica, ha stipulato un accordo definitivo con Numab Therapeutics, una società di biotecnologie in fase clinica che promuove una pipeline di terapie immunologiche e oncologiche, per ...

7. www.investor.jnj.com › news › news-detailsJohnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific...

   www.investor.jnj.com › news › news-details

   • Cache

   5 giorni fa · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and oncology therapeutics, to acquire from Numab's shareholders its wholly-owned subsidiary for the global rights to a novel, investigational first-in-class bispecific ...

8. www.reuters.com › markets › companiesJNJ.N - | Stock Price & Latest News | Reuters

   www.reuters.com › markets › companies

   1 giorno fa · Get Johnson & Johnson (JNJ.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.